As an experienced investor with a background in science and medicine, I’ve developed a keen ability to identify startups with strong potential for growth, resilience, and profitability. I invest across both seed-stage ventures—where risk is high but the upside can be extraordinary—and later-stage, pre-IPO companies.

The key to success for any startup lies in a well-structured business plan that fosters sustainable traction, whether through rapid user or customer acquisition or the development of a healthy revenue stream. I prioritize companies that have carved out a clear niche and are led by individuals with a strong sense of purpose and determination.

After more than ten years of angel investing, I believe I’ve discovered the key ingredients for selecting groups of companies with high growth potential and long-term sustainability.

Angel investing is inherently risky, and it’s important to understand that you can lose all of your invested capital in any given deal. For that reason, I strongly advise allocating no more than 3–5% of your liquid net worth to angel investments.